Restricted accessResearch articleFirst published online 1995-2
Ruolo della citometria d'immagine: Correlazione con PSA,Gleason score,stadiazione anatomo patologica e follow-up: The role of image cytometry: Correlation with PSA,Gleason score,pathological stage and follow-up
de Vere WhitwR., PaulsonD.F., GlennJ.F.: The clinical spectrum of prostate cancer. J. Urol., 117: 303–327, 1977.
2.
CatalonaW.J., ScottW.W.: Carcinoma of the prostate: A review. J. Urol., 119: 1–8, 1978.
3.
VisakorpiT., KallioniemiO.P., KoivulaT., IsolaJ.: New prognostic factors in prostatic carcinoma. Eur. Urol., 24: 438–449, 1993.
4.
NativO., LieberM.M.: Prostatic carcinoma: prognostic importance of static and flow cytometric nuclear DNA ploidy measurements. AUA Update Series 23, Vol. X: 178–183, 1991.
5.
StephensonR.A.: Flow cytometry in genitourinary malignancies using paraffin-embedded material. Sem. Urol., 6: 46–52, 1988.
6.
JonesE.C., McNealJ., BruchovskyN.: DNA content in prostatic adenocarcinoma. A flow cytometry study of the predictive value of aneuploidy for tumor volume, percentage Gleason 4 and 5, and lymph node metastases. Cancer, 66: 752–757, 1990.
7.
RitchieA.W.: Relationship of DNA content to conventional prognostic factors in clinically localized carcinoma of the prostate. Br. J. Urol., 62: 245–260, 1988.
8.
LundbergS., CarstensenJ., RundquistI.: DNA flow cytometry and histopatological grading of paraffin-embedded prostate biopsy specimens in a survival study. Cancer res., 47: 1973–1977, 1987.
9.
EkmanP., SvennerusK., ZetterbergA., GustafsonJ.A.: Cytophotometric DNA analyses and steroid receptor content in human prostate carcinoma. Scand. J. Urol. Nephrol., Suppl.60: 85–88, 1989.
10.
BacusS.S., BacusJ.W., BacusJ.V., ChinD.M., OrtizR., SternR.K., MorrowD.W.: Prostate adenocarcinoma: an Image Analysis Technique for DNA ploidy determination. Lab. Med., 24, 4: 225–231, 1993.
11.
PetersJ.M., MilesB.J., KubusJ.J., CrissmanJ.P.: Prognostic significance of the nuclear DNA content in localized prostatic adenocarcinoma. Anal. Quant. Cytol. Histol., 12: 359–365, 1990.
12.
EpsteinJ.I., ChristensenW.N., SteinbergG.D., CarterH.B.: Comparison of DNA ploidy and nuclear size, shape and tissue chromatin irregularity in tissue sections and smears of prostatic carcinoma. Anal. Quant. Cytol. Histol., 12: 352–358, 1990.
13.
GreeneD.R., TaylorS.R., WheelerT.M., ScardinoP.T.: DNA ploidy by Image Analysis of individual foci of prostate cancer: a preliminary report. Cancer Res., 51: 4084–4089, 1991.
14.
HedlundP.O., EspostiP., FalkmerU., GiacobssonH.: DNA as a prognostic marker in advanced high-grade prostatic cancer. Acta Oncol., 30: 215–217, 1991.
15.
EpsteinJ.I., PizovG., SteinbergG.D., CarterH.B., PitcockR., ArmasO.A., PartinA., WalshP.C.: Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with clinicopathological stage in radical prostatectomy. J. Urol., 148: 87–91, 1992.
16.
DeijterS.W., CunninghamR.E., NoguchiP.D., JonesR.V., MoulJ.W., McLeodD.G., LynchJ.H.: Prognostic significance of DNA ploidy in carcinoma of prostate. Urology, 33: 361–366, 1989.
17.
RingK.S., KarpF.S., OlssonC.A., O'TooleK., BixonR., BensonM.C.: Flow Cytometric Analysis of localized adenocarcinoma of the prostate: the use of archival DNA analysis in conjunction with pathological grading to predict clinical outcome following radical retropubic prostatectomy. Prostate, 17: 155–164, 1990.
18.
RitchieA.W., DoreyF., LayfieldL.J., HannahJ., LovrekovichHJ., de KernionG.B.: Relationship of DNA content to conventional prognostic factors in clinical localized carcinoma of the prostate. Br. J. Urol., 62: 245–260, 1988.
